Ligand Pharmaceuticals
LGND
#3601
Rank
A$5.47 B
Marketcap
A$278.32
Share price
-1.93%
Change (1 day)
45.34%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Net assets

Net assets on the balance sheet as of September 2025 : A$1.43 Billion

According to Ligand Pharmaceuticals's latest financial reports the company has A$1.43 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Ligand Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$1.33 B29.78%
2023-12-31$A$1.02 B17.17%
2022-12-31$A$0.87 B-22.48%
2021-12-31$A$1.13 B22.75%
2020-12-31$A$0.92 B-15.79%
2019-12-31$A$1.09 B37.63%
2018-12-31$A$0.79 B48.48%
2017-12-31$A$0.53 B4.23%
2016-12-31$A$0.51 B35.35%
2015-12-31$A$0.38 B1174.52%
2014-12-31$A$29.82 M-46.38%
2013-12-31$A$55.62 M118.24%
2012-12-31$A$25.48 M219.27%
2011-12-31$A$7.98 M-267.22%
2010-12-31$-A$4.78 Million-214.54%
2009-12-31$A$4.16 M-128.37%
2008-12-31$-A$14.7 Million-144.12%
2007-12-31$A$33.3 M-4.02%
2006-12-31$A$34.69 M-122.99%
2005-12-31$-A$0.16 Billion55.05%
2004-12-31$-A$97.33 Million92.64%
2003-12-31$-A$50.53 Million-138.46%
2002-12-31$A$0.13 B-215.85%
2001-12-31$-A$0.12 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Amgen
AMGN
A$14.48 B 912.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A$40.35 M-97.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$31.88 B 2,128.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$78.14 B 5,362.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$140.15 B 9,697.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$35.90 B 2,410.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$28.00 B 1,857.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$10.86 B 659.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$119.35 B 8,243.45%๐Ÿ‡บ๐Ÿ‡ธ USA